Total Payments
$823,191
2024 Payments
$50,638
Companies
35
Transactions
1,442
Medicare Patients
7,046
Medicare Billing
$925,993
Payment Breakdown by Category
Other$687,829 (83.6%)
Travel$56,980 (6.9%)
Consulting$41,938 (5.1%)
Food & Beverage$36,135 (4.4%)
Education$269.36 (0.0%)
Gifts$40.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $687,829 | 233 | 83.6% |
| Travel and Lodging | $56,980 | 239 | 6.9% |
| Consulting Fee | $41,938 | 23 | 5.1% |
| Food and Beverage | $36,135 | 932 | 4.4% |
| Education | $269.36 | 14 | 0.0% |
| Gift | $40.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $311,973 | 265 | $0 (2024) |
| GlaxoSmithKline, LLC. | $145,724 | 194 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $136,658 | 134 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123,523 | 318 | $0 (2024) |
| Insmed, Inc. | $37,955 | 75 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $31,000 | 103 | $0 (2020) |
| Mylan Specialty L.P. | $17,942 | 65 | $0 (2024) |
| United Therapeutics Corporation | $12,832 | 27 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $1,078 | 51 | $0 (2024) |
| Philips Electronics North America Corporation | $630.76 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50,638 | 113 | Mallinckrodt Hospital Products Inc. ($44,509) |
| 2023 | $44,351 | 116 | GlaxoSmithKline, LLC. ($13,556) |
| 2022 | $120,644 | 170 | Mallinckrodt Hospital Products Inc. ($85,164) |
| 2021 | $120,680 | 179 | Mallinckrodt Hospital Products Inc. ($63,767) |
| 2020 | $151,134 | 175 | Mallinckrodt Hospital Products Inc. ($106,045) |
| 2019 | $181,045 | 293 | Mallinckrodt Enterprises LLC ($74,812) |
| 2018 | $61,253 | 190 | Boehringer Ingelheim Pharmaceuticals, Inc. ($29,884) |
| 2017 | $93,446 | 206 | Mallinckrodt LLC ($42,800) |
All Payment Transactions
1,442 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $15.94 | General |
| Category: Medical Device | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,320.00 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $83.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $30.12 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Cardio-pulmonary | ||||||
| 11/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $124.62 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,620.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,465.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,576 | 2,667 | $686,781 | $211,213 |
| 2022 | 30 | 1,636 | 2,523 | $587,917 | $200,033 |
| 2021 | 32 | 1,856 | 2,970 | $761,955 | $242,688 |
| 2020 | 36 | 1,978 | 3,129 | $830,490 | $272,059 |
Total Patients
7,046
Total Services
11,289
Medicare Billing
$925,993
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 494 | $160,550 | $55,774 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 98 | 148 | $46,425 | $23,276 | 50.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 40 | 98 | $59,039 | $19,568 | 33.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 40 | 267 | $41,150 | $16,814 | 40.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 107 | $26,750 | $11,802 | 44.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 44 | 54 | $16,770 | $8,641 | 51.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 54 | $18,900 | $8,552 | 45.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 135 | 144 | $29,880 | $7,886 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 82 | $22,500 | $6,887 | 30.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 96 | $14,648 | $6,687 | 45.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 135 | 144 | $26,120 | $6,077 | 23.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 107 | 185 | $87,700 | $5,656 | 6.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 140 | 152 | $60,528 | $5,642 | 9.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $20,715 | $5,037 | 24.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 27 | 27 | $7,646 | $3,557 | 46.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 89 | 189 | $6,648 | $3,302 | 49.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 48 | 48 | $8,961 | $2,413 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $2,625 | $2,277 | 86.7% |
| 82805 | Blood gases measurement, with o2 saturation | Office | 2023 | 19 | 26 | $2,947 | $2,007 | 68.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 21 | $2,553 | $1,601 | 62.7% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 11 | 11 | $8,250 | $1,445 | 17.5% |
| 31502 | Change of breathing tube in windpipe | Facility | 2023 | 25 | 49 | $4,944 | $1,391 | 28.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 13 | 16 | $1,600 | $1,114 | 69.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $1,050 | $1,029 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 54 | 98 | $1,479 | $823.20 | 55.7% |
About Dr. Jack Mann, M.D
Dr. Jack Mann, M.D is a Pulmonary Disease healthcare provider based in Bayside, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376542217.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Mann, M.D has received a total of $823,191 in payments from pharmaceutical and medical device companies, with $50,638 received in 2024. These payments were reported across 1,442 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($687,829).
As a Medicare-enrolled provider, Mann has provided services to 7,046 Medicare beneficiaries, totaling 11,289 services with total Medicare billing of $925,993. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Bayside, NY
- Active Since 07/20/2005
- Last Updated 04/09/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376542217
Products in Payments
- ACTHAR (Biological) $448,632
- TRELEGY ELLIPTA (Drug) $79,425
- OFEV (Drug) $41,691
- Arikayce (Drug) $35,330
- NUCALA (Biological) $31,323
- LONHALA MAGNAIR (Drug) $18,627
- Yupelri (Drug) $17,676
- ANORO (Drug) $13,094
- UTIBRON (Drug) $12,039
- SPIRIVA RESPIMAT (Drug) $2,669
- SPIRIVA (Drug) $1,390
- STIOLTO RESPIMAT (Drug) $1,149
- OPSUMIT (Drug) $615.96
- Prolastin-C Liquid (Biological) $534.72
- Adempas (Drug) $492.66
- DUPIXENT (Biological) $396.51
- ANORO ELLIPTA (Drug) $305.21
- GLASSIA (Biological) $297.45
- UPTRAVI (Drug) $214.55
- Esbriet (Biological) $204.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.